What’s available: 3,000 FDA-approved drugs, countless nutriceuticals and 1000s of devices The Problem: 90% of all patients will not see an effective treatment in their lifetime and for 12,000 diseases, only 30-40 new drugs are approved annually What can be done: With 25 research partners, and less than $7M in philanthropic funds, we have created 9 repurposed treatments changing the lives of thousands of patients What can be done: With 25 research partners, and less than $7M in philanthropic funds, we have created 9 repurposed treatments changing the lives of thousands of patients

 

Cures Within Reach catalyzes repurposing research to quickly and affordably improve patient lives.  Cures Within Reach leverages the speed, safety and cost-effectiveness of medical repurposing research, driving more treatments to more patients more quickly.

 

NEW:  Listen to Barbara Goodman share our Impact Philanthropy model and the power of repurposing to impact patients faster on a recent podcast episode of DIA Global.

DIA podcast BG image

 

REPURPOSING AND COVID19

Repurposing Trials for COVID19:  The global healthcare community is working together in unprecedented ways to treat patients and learn from each other. There are many opportunities underway using already approved drugs in clinical trials to treat COVID19 patients, providing evidence based medicine to clinicians.  Read more about the many clinical repurposing trials at these sites:

  1. BioCentury’s updated table of the 200+ ongoing trials
  2. ReDo Project led by AntiCancer Fund
  3. Reagan-Udall Foundation for the FDA: COVID19 Treatment Hub as well as its COVID19 Evidence Accelerator

Resources for Repurposing in COVID19​

  1. CURE ID: case reporting tool from NIH/NCATS and FDA
  2. NIH - NCATS COVID OpenData Portal 
  3. Funding Source: NIH/NCATS: Urgent Phase I/II Clinical Trials to Repurpose Existing Therapeutic Agents to Treat COVID-19
  4. U Penn's CORONA (COvid Registry of Off-label & New Agents) database
  5. Data Against COVID19: data sharing platform  ​
  6. XSEDE’s HPC-COVID19 Consortium: computing resources

 

Why is Repurposing important? 

Repurposing101

Click here to sign up for our eNewsletter today!

Please include your Full Name* and Email Address*

*required

If the link above doesn't work, please contact our Admin support at admin@cureswithinreach.org with your Full Name and Email Address to sign up!

 

FacebookLinkedinTwitterYoutube
Social Media Icons for Joomla!

Cures Within Reach

134 N. LaSalle, #1130
Chicago, IL 60602

info@cureswithinreach.org

All funds donated to Cures Within Reach may be tax deductible for federal income tax purposes. 

Partnership for Cures DBA Cures Within Reach is recognized by the IRS as a 501(c)3 tax-exempt not-for-profit organization, tax ID 20-3620169.

 

Sunday the 20th. Copyright 2018 Cures Within Reach.